BIAFW | bioAffinity Technologies, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5000 - 0.8000
52 Week Range	0.5000 - 0.8000
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	186,128
Average Volume	5,173
Shares Outstanding	15,584,635
Market Cap	9,350,781
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	75
Country	USA
Website	BIAFW

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BIAFW's peers: APCXW, AWH, GFAIW, IINNW, ISPC, NDRA, RDNT, SVREW, TCBPW, LUCYW, GREEL, BIAF, AAPJ, DPUI, CDSG, PKBO, JFBRW

*Chart delayed

Analyzing fundamentals for BIAFW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see BIAFW Fundamentals page.

Watching at BIAFW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on BIAFW Technicals page.